Powered by

Hogan Lovells Represents LabCorp in Net U.S. $485 Million Complex Strategic Acquisition and Divestiture

Apr 17, 2019 - Targeted News Service
Mergers and Acquisitions

Hogan Lovells, a multinational law firm, issued the following news release:

New York, Washington - Hogan Lovells is representing LabCorp, a leading global life sciences company, in a complex two-way acquisition and divestiture transaction with Envigo, a leading provider of nonclinical contract research services and research models. Under the signed agreements, LabCorp's Covance Drug Development segment will acquire Envigo's nonclinical contract research services business, and Envigo will a...